Calypso said its system will be implemented to provide valuation for a wide array of OTC derivatives to ensure that each trade meets the predefined parameters set by BM&FBOVESPA.
BM&FBOVESPA chief products and customers officer Marcelo Maziero said with the Calypso platform, BM&FBOVESPA intends to modernize, enhance and expand its OTC operations registration service, offering quality and agility to its customers, and complete analysis instruments for self-regulation and regulatory activities.
Calypso Technology chairman and CEO Charles Marston they look forward to working with BM&FBOVESPA to develop the future market structure for OTC derivatives and other products in Brazil.
